Welcome to www.pliva.com







Back

December 2008
  2008-12-23 PLIVA Notes Teva's Announcement on Completion of Acquisition of Barr
 
  2008-12-22 PLIVA Notes Barr Announcements on Clearance by the U.S. Federal Trade Commission and the European Commission of Teva's Acqusition of Barr
 

November 2008
  2008-11-24 PLIVA Notes Barr Announcement on Barr Shareholders' Approval of Pending Teva Acquisition
 
  2008-11-07 PLIVA Announces Nine Month 2008 Results
 

October 2008
  2008-10-31 PLIVA to Announce 2008 Nine Month Financial Results on 07 November 2008
 

August 2008
  2008-08-26 PLIVA Announces Results of Annual General Shareholders' Meeting Held Today
 
  2008-08-08 PLIVA Announces H1 2008 Results
 
  2008-08-02 PLIVA to Announce First Half 2008 Financial Results on 08 August 2008
 

July 2008
  2008-07-25 PLIVA Announces Delisting of PLIVA's Securities from LSE
 
  2008-07-18 PLIVA Notes Barr and Teva Announcement
 
  2008-07-14 PLIVA Announces Annual General Shareholders' Meeting To Be Held on 26 August 2008
 

June 2008
  2008-06-20 PLIVA Announces Termination of GDR Deposit Agreement
 

May 2008
  2008-05-09 PLIVA Announces Q1 2008 Results
 

April 2008
  2008-04-30 PLIVA to Announce Q1 2008 Financial Results on 09 May 2008
 
  2008-04-21 PLIVA Announces Early Repayment of Bonds
 
  2008-04-18 PLIVA Announces Share Capital Increase
 
  2008-04-07 PLIVA Announces its Intention to Amend Bond Terms
 
  2008-04-01 PLIVA Announces Changes to Management Board
 

March 2008
  2008-03-31 PLIVA Announces 2007 Results
 
  2008-03-25 Notice of PLIVA's Management and Supervisory Boards Meeting
 
  2008-03-18 PLIVA Announces Termination of GDR Deposit Agreement
 
  2008-03-10 PLIVA Announces Results of Extraordinary General Shareholders' Meeting Held Today
 

January 2008
  2008-01-29 PLIVA Announces Extraordinary General Shareholders' Meeting To Be Held on 10 March 2008
 
  2008-01-25 PLIVA Announces Change in Management Board
 

December 2007
  2007-12-31 PLIVA Divests Spanish Operations
 

November 2007
  2007-11-12 PLIVA Announces Nine Months 2007 Results
 
  2007-11-02 PLIVA to Announce Q3 2007 Financial Results on 12 November 2007
 

October 2007
  2007-10-09 Interim Results of the Public Offering of VETERINA d.d. Shares
 
  2007-10-03 Addendum to Public Offering of Veterina d.d. Shares
 
  2007-10-01 PLIVA Divests Italian Operations
 

September 2007
  2007-09-28 PLIVA Announces Public Offering of Veterina d.d. Shares
 
  2007-09-05 PLIVA Enters Oncology Business in Germany
 

August 2007
  2007-08-24 PLIVA Announces Results of its Annual General Meeting
 
  2007-08-10 PLIVA Announces First Half 2007 Results
 
  2007-08-02 PLIVA Announces Departure of Paul M. Bisaro
 

July 2007
  2007-07-24 PLIVA to announce Q2 2007 Financial Results on 10 August 2007
 
  2007-07-11 PLIVA Announces Agenda of its Annual General Meeting
 

May 2007
  2007-05-11 PLIVA Announces Q1 2007 Results
 
  2007-05-03 PLIVA to announce Q1 2007 Financial Results on 11 May 2007
 

April 2007
  2007-04-16 PLIVA Announces Date of AGM
 
  2007-04-16 PLIVA Announces Transfer of US business to Barr
 
  2007-04-02 PLIVA Announces 2006 Results
 

March 2007
  2007-03-23 PLIVA to announce FY 2006 Financial Results on 02 April 2007
 

February 2007
  2007-02-22 PLIVA Files Lawsuit Against HANFA
 

January 2007
  2007-01-24 PLIVA to File Lawsuit Against HANFA
 

December 2006
  2006-12-20 Election of President and Vice President of PLIVA's Supervisory Board
 
  2006-12-19 Results of PLIVA’s Extraordinary General Assembly
 

November 2006
  2006-11-28 PLIVA Receives Approval for Pravastatin Tablets 10mg, 20mg, and 40mg and Tentative Approval for 80mg
 
  2006-11-09 PLIVA Announces Agenda of its Annual General Meeting
 
  2006-11-08 PLIVA Announces Q3 2006 Results
 

October 2006
  2006-10-31 PLIVA Announces Changes in Management and Supervisory Boards
 
  2006-10-25 PLIVA to Announce Q3 2006 Financial Results on 08 November 2006
 
  2006-10-24 Barr Completes Payment for PLIVA Shares
 
  2006-10-20 Barr Acquires PLIVA d.d.
 
  2006-10-20 webcast: Barr Acquires PLIVA d.d. - Conference Call and Webcast
 

September 2006
  2006-09-18 Notice of Withdrawal of Actavis Takeover Bid for PLIVA
 
  2006-09-11 Notice of Amendment to Barr's Takeover Bid
 
  2006-09-08 PLIVA Supervisory Board Announces Opinion on Actavis Offer
 
  2006-09-07 PLIVA Announces Q2 2006 Results
 
  2006-09-07 Announcement Regarding Actavis Takeover Bid for PLIVA d.d. Published in Official Gazette
 
  2006-09-06 webcast: Q2 & H1 2006 Results Conference Call and Webcast
 
  2006-09-01 PLIVA Completes Dividend Payment
 

August 2006
  2006-08-31 PLIVA Notes Suspension of Trading of Shares on ZSE
 
  2006-08-31 PLIVA Notes HANFA’s Approval of Actavis Offer
 
  2006-08-31 PLIVA to Announce Q2 2006 Financial Results on 07 September 2006
 
  2006-08-29 PLIVA Announces Results of its Annual General Meeting
 
  2006-08-23 PLIVA Supervisory Board Announces Opinion on Barr Offer
 
  2006-08-18 Announcement Regarding Barr Takeover Bid for PLIVA d.d. Published in Official Gazette
 

July 2006
  2006-07-27 PLIVA and Mayne Pharma Finalise Agreement to Continue Development of G-CSF
 
  2006-07-20 PLIVA Announces Agenda of its Annual General Meeting
 
  2006-07-19 PLIVA Announces Amended Notification from Actavis
 
  2006-07-17 PLIVA Announces Dates of Annual General Meeting & Dividend
 
  2006-07-14 Announcement of Notification
 
  2006-07-07 PLIVA Announces FDA Approvals for Azithromycin Oral Suspension, Warfarin and Ondansetron Hydrochloride
 
  2006-07-05 PLIVA Comments on Actavis’ Intention to Publish Offer
 

June 2006
  2006-06-30 PLIVA Comments on Actavis and Barr Announcements
 
  2006-06-27 PLIVA endorses proposal from Barr
 
  2006-06-27 webcast: PLIVA Endorses Proposal from Barr Conference Call and Webcast
 
  2006-06-26 PLIVA considers a number of final proposals
 
  2006-06-14 PLIVA Opens New Biostudy Center in Goa
 

May 2006
  2006-05-18 PLIVA Signs Agreement with Unichem for New Products in US
 
  2006-05-17 IFC Converts Loan to PLIVA GDRs
 
  2006-05-11 Correction to Q1 2006 Conference Call Dial in Numbers
 
  2006-05-11 PLIVA Announces Q1 2006 Results
 
  2006-05-08 PLIVA Implements Corrective Plan to Address FDA Warning Letter
 
  2006-05-05 PLIVA Completes Divestment of Research Institute
 
  2006-05-04 PLIVA Completes Divestment of Its Manufacturing Plant in Germany
 
  2006-05-04 PLIVA to Announce Q1 2006 Financial Results on 11 May 2006
 

April 2006
  2006-04-24 PLIVA's 2005 Annual Report now available online
 
  2006-04-20 PLIVA to seek clarification of Actavis offer
 
  2006-04-12 PLIVA Launches Contribute to Organic Growth
 
  2006-04-06 PLIVA’s Supervisory and Management Boards Discuss Strategic Options
 

March 2006
  2006-03-17 PLIVA Comments on Actavis Announcement
 
  2006-03-01 PLIVA Announces Q4 2005 Results
 

February 2006
  2006-02-28 webcast: Q4 & FY 2005 Results Conference Call and Webcast
 
  2006-02-22 PLIVA and Mayne Partnership on Biosimilars updated: GCSF to continue, EPO to terminate
 
  2006-02-15 PLIVA Acquires Uso Racional in Spain
 
  2006-02-14 PLIVA Successfully Completes Exit from Proprietary Business
 

January 2006
  2006-01-26 PLIVA Divests AWD Manufacturing Plant
 

December 2005
  2005-12-23 PLIVA Announces Tentative Approval for Sertraline Hydrochloride Tablets
 
  2005-12-14 PLIVA Launches Generic Azithromycin Tablets in the US
 

November 2005
  2005-11-21 PLIVA Announces Approval for Ondansetron Hydrochloride ODT
 
  2005-11-15 PLIVA Announces Approval for Azithromycin Tablets
 
  2005-11-09 PLIVA Announces Q3 2005 Results
 
  2005-11-08 PLIVA Completes Divestment of VoSpire
 
  2005-11-04 PLIVA Announces Approval for Citalopram Hydrobromide Tablets
 
  2005-11-04 PLIVA Announces Tentative Approval for Zolpidem Tartrate Tablets
 

October 2005
  2005-10-29 PLIVA to Announce Q3 2005 Results
 
  2005-10-03 PLIVA Terminates Agreements with Legacy Pharma
 

September 2005
  2005-09-28 PLIVA to Divest VoSpire from US Proprietary Portfolio
 
  2005-09-26 PLIVA Signs New Bulk Azithromycin Supply Agreement
 
  2005-09-07 PLIVA Announces Q2 2005 Results
 
  2005-09-05 Webcast: H1 Results Announcement 7 September 2005
 

August 2005
  2005-08-01 PLIVA Divests CNS Franchise from Proprietary Portfolio
 

July 2005
  2005-07-14 New Mandate for PLIVA’s Management Board
 
  2005-07-04 PLIVA Completes Divestment of SANCTURA
 

June 2005
  2005-06-21 PLIVA Registers generic EPO in Croatia
 
  2005-06-14 PLIVA Announces Results of its Annual General Meeting
 

May 2005
  2005-05-23 PLIVA to Present at UBS – 2005 Global Pharmaceuticals Conference
 
  2005-05-16 PLIVA to Present at BAS - Health Care Conference
 
  2005-05-15 PLIVA to Exit Proprietary Business and Divest SANCTURA
 
  2005-05-05 PLIVA Announces Q1 2005 Results
 
  2005-05-05 PLIVA Announces Agenda of its Annual General Meeting
 
  2005-05-04 Correction - Q1 2005 Conference Call and Webcast Details
 

April 2005
  2005-04-28 PLIVA's 2004 Annual Report now available online
 
  2005-04-22 PLIVA Announces Date of Annual General Meeting
 

March 2005
  2005-03-30 Barr and PLIVA Sign Agreement to Develop and Market Generic Version of G-CSF in United States and Canada
 
  2005-03-02 PLIVA Announces FY 2004 Results
 

February 2005
  2005-02-22 PLIVA and Mayne Enter Biogeneric Partnership
 

December 2004
  2004-12-03 PLIVA Announces Revised 2004 Outlook
 

November 2004
  2004-11-04 Q3 Conference Call Details & Presentation
 
  2004-11-04 Changes in PLIVA’s Management Board
 
  2004-11-04 PLIVA Announces Q3 2004 Results
 
  2004-11-02 PLIVA Q3 Results Conference Call Announcement
 

October 2004
  2004-10-29 PLIVA announces USD 250 million Syndicated Loan
 
  2004-10-15 PLIVA Awarded as "Best IR from a non-EU C&EE country"
 

December 2003
  2003-12-15 PLIVA Hrvatska d.o.o. – among ten leading Croatian companies
 
  2003-12-10 Changes in PLIVA’s Management Board
 

July 2003
  2003-07-25 Special Announcement
 
  2003-07-24 PLIVA and HYPERION sign agreement about Corporate Performance Management software
 
  2003-07-11 PLIVA and the "Ruder Boskovic" Institute contracted financing of the PhDs-to-be
 

June 2003
  2003-06-13 Marija Mandic – New director of PLIVA's Corporate Communications
 
  2003-06-12 PLIVA in the Hall of Fame
 

April 2003
  2003-04-23 PLIVA and Microsoft expand their strategic partnership
 

March 2003
  2003-03-04 PLIVA®, Inc. - New Name for Sidmak Laboratories, Inc.
 

February 2003
  2003-02-25 SMSlijek – world’s unique SMS service Coming from PLIVA and HTmobile in cooperation
 

January 2003
  2003-01-27 Azithromycin and Chlamydia
 

December 2002
  2002-12-20 "Magic at Lisinski"
 

October 2002
  2002-10-15 PLIVA's Scientific Forum held
 
  2002-10-09 President Mesic opens PLIVA's new Research Institute
 

September 2002
  2002-09-30 The opening of PLIVA's new Research Institute
 
  2002-09-20 PLIVA registers first drug in Western Europe
 
  2002-09-18 PLIVA Nordic affiliates change name
 

July 2002
  2002-07-25 Dominion Pharma Ltd - new name and address
 

June 2002
  2002-06-04 Stability Pact Business Advisory Council Conference
 

May 2002
  2002-05-21 PLIVA Krakow receives ISO 14001 certificate
 

April 2002
  2002-04-18 PLIVA launches Italian business
 

March 2002
  2002-03-29 PLIVA - general sponsor of the 25th EPSA Congress
 
  2002-03-18 PLIVA's healthcare and medical portals receive confirmation of quality
 
  2002-03-13 PLIVA major contributor at ICMAS-KO 6
 

February 2002
  2002-02-28 PLIVA and SAP sign new global licensing agreement for mySAP.com E-business platform
 

December 2001
  2001-12-12 State-of-the-art facility
 

October 2001
  2001-10-19 The central celebration of PLIVA's 80th anniversary has been cancelled
 
  2001-10-03 CEO of PLIVA opens new Development Center in AWD.pharma
 
  2001-10-02 PLIVA's scholarships for the most talented students in Croatia, the Czech Republic and Poland
 

September 2001
  2001-09-28 PLIVA launches two Internet medical portals
 

August 2001
  2001-08-30 German Cartel Office approves acquisition of AWD.pharma
 

July 2001
  2001-07-23 PLIVA d.d. corporate holidays
 

June 2001
  2001-06-07 PLIVA Lachema's new phone numbers
 

May 2001
  2001-05-03 PLIVA IT Scholarships
 

April 2001
  2001-04-22 PLIVA receives award from EBRD
 

March 2001
  2001-03-19 Duke graduates visit Central and Eastern Europe - PLIVA as an example
 

February 2001
  2001-02-13 PLIVA finalises latest investment
 

January 2001
  2001-01-18 PLIVA and Microsoft sign global purchasing agreement
 

December 2000
  2000-12-08 Simplified Customs Procedures for the Company
 
  2000-12-08 Engineer from PLIVA wins Golden Award for innovation
 

November 2000
  2000-11-15 PLIVA's SUBSIDIARY NEVA D.O.O. OBTAINS THE ISO 14001 ENVIRONMENTAL MANAGEMENT SYSTEM CERTIFICATION
 
  2000-11-14 ENCOURAGEMENT TO YOUNG SCIENTISTS
 

September 2000
  2000-09-28 STATE AND BUSINESS DELEGATION FROM TURKEY VISITS PLIVA
 

July 2000
  2000-07-18 SPECIAL ANNOUNCEMENT
 

December 1999
  1999-12-06 Y2K PREPARATIONS
 

October 1998
  1998-10-05 RESPONSE TO SPECULATION RELATING TO LEK
 

September 1998
  1998-09-14 PLIVA ACQUIRES YEAST FACTORY IN SLOVAKIA
 
  1998-09-04 PLIVA OPENS NEW STATE-OF-THE-ART AZITHROMYCIN PRODUCTION FACILITY
 

May 1998
  1998-05-13 SECONDARY OFFERING OF PLIVA SHARES: INSTITUTIONAL PRICE FIXED AT US$ 16.60 PER GDR STRONG INTERNATIONAL AND DOMESTIC DEMAND SHOWN
 

teva_memberOfGroup_mali.jpg






Copyright © 1998-2010 PLIVA d.d. All rights reserved. Important legal information. Impressum.